Premium O3‐10‐05: MODULATION OF MICRORNA PATHWAYS BY GEMFIBROZIL IN PREDEMENTIA ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO‐CONTROLLED, DOUBLE‐BLIND CLINICAL TRIALPremium
Author(s)
Jicha Gregory A.,
Kryscio Richard J.,
Beech Brooke F.,
Wang Wang-Xia,
Lynn Bert C.,
Schmitt Frederick A.,
Coy Beth,
Al-Janabi Omar M.,
Abner Erin L.,
Nelson Peter T.
Publication year2019
Publication title
alzheimer's and dementia
Resource typeJournals
PublisherWiley
Subject(s)adverse effect , alternative medicine , cholesterol , clinical trial , endocrinology , environmental health , gemfibrozil , medicine , oncology , pathology , pharmacology , placebo , population , randomized controlled trial
Language(s)English
SCImago Journal Rank6.713
H-Index118
eISSN1552-5279
pISSN1552-5260
DOI10.1016/j.jalz.2019.06.4682
Seeing content that should not be on Zendy? Contact us.